← Back to Search

Hearing Aid

Hearing Aid for Age-Related Hearing Loss (P-EARLHI Trial)

N/A
Recruiting
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at time of study enrollment; between 6- and 8-weeks post study enrollment; and at 6-months post study enrollment
Awards & highlights
No Placebo-Only Group

Summary

This trial studies the effects of hearing aid intervention in adults 55-75 with hearing loss, to improve their physical, social, and quality of life outcomes.

Who is the study for?
This trial is for adults aged 55 to 75 who have early age-related hearing loss and haven't really used hearing aids before. They must be able to speak English or Spanish and fill out questionnaires on a tablet without help. People with certain cognitive issues that affect their ability to participate are not eligible.
What is being tested?
The study is testing the Phonak Audeo Lumity Receiver in Canal Hearing Aid to see if it improves hearing outcomes in older adults. It's part of a bigger project aiming to understand how using high-quality hearing aids affects daily life, social activities, and overall well-being.
What are the potential side effects?
While specific side effects aren't listed for this device, common issues with new hearing aids can include discomfort while wearing them, feedback noises, and an adjustment period where sounds may seem unusual or too loud.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at time of study enrollment; between 6- and 8-weeks post study enrollment; and at 6-months post study enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at time of study enrollment; between 6- and 8-weeks post study enrollment; and at 6-months post study enrollment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Objective Physical Activity
Secondary study objectives
Baecke Physical Activity Questionnaire
Center for Epidemiological Studies Depression and Hopelessness Scale
Client Oriented Scale of Improvement
+15 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Hearing Intervention GroupExperimental Treatment1 Intervention
Adults aged 55-75 with hearing loss who have little/no prior experience with hearing aids will be enrolled in the hearing intervention group.

Find a Location

Who is running the clinical trial?

University of South FloridaLead Sponsor
426 Previous Clinical Trials
191,799 Total Patients Enrolled

Media Library

Phonak Audeo Lumity Receiver in Canal Hearing Aid (Hearing Aid) Clinical Trial Eligibility Overview. Trial Name: NCT05970211 — N/A
Neonatal Hearing Loss Research Study Groups: Hearing Intervention Group
Neonatal Hearing Loss Clinical Trial 2023: Phonak Audeo Lumity Receiver in Canal Hearing Aid Highlights & Side Effects. Trial Name: NCT05970211 — N/A
Phonak Audeo Lumity Receiver in Canal Hearing Aid (Hearing Aid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05970211 — N/A
~17 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top